107 related articles for article (PubMed ID: 31173970)
1. Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis.
Lee SJ; Gharbi A; You JS; Han HD; Kang TH; Hong SH; Park WS; Jung ID; Park YM
Int Immunopharmacol; 2019 Aug; 73():482-490. PubMed ID: 31173970
[TBL] [Abstract][Full Text] [Related]
2. LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent.
Han HW; Hahn S; Jeong HY; Jee JH; Nam MO; Kim HK; Lee DH; Lee SY; Choi DK; Yu JH; Min SH; Yoo J
Sci Rep; 2018 Oct; 8(1):14969. PubMed ID: 30297806
[TBL] [Abstract][Full Text] [Related]
3. Epinecidin-1 protects mice from LPS-induced endotoxemia and cecal ligation and puncture-induced polymicrobial sepsis.
Su BC; Huang HN; Lin TW; Hsiao CD; Chen JY
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3028-3037. PubMed ID: 28882626
[TBL] [Abstract][Full Text] [Related]
4. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
Liu S; Marneth AE; Alexe G; Walker SR; Gandler HI; Ye DQ; Labella K; Mathur R; Toniolo PA; Tillgren M; Gokhale PC; Barbie D; Mullally A; Stegmaier K; Frank DA
Blood Adv; 2018 Dec; 2(23):3428-3442. PubMed ID: 30504235
[TBL] [Abstract][Full Text] [Related]
5. Repositioning of the antipsychotic drug TFP for sepsis treatment.
Park JH; Park HJ; Lee SE; Kim YS; Jang GY; Han HD; Jung ID; Shin KC; Bae YM; Kang TH; Park YM
J Mol Med (Berl); 2019 May; 97(5):647-658. PubMed ID: 30848296
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
Xiang XS; Li N; Zhao YZ; Li QR; Li JS
Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
[TBL] [Abstract][Full Text] [Related]
7. ALK is a therapeutic target for lethal sepsis.
Zeng L; Kang R; Zhu S; Wang X; Cao L; Wang H; Billiar TR; Jiang J; Tang D
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046432
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of pro-inflammatory mediators by a water extract of Schisandra chinensis (Turcz.) Baill fruit in lipopolysaccharide-stimulated RAW 264.7 macrophage cells.
Dilshara MG; Jayasooriya RGPT; Kang CH; Lee S; Park SR; Jeong JW; Choi YH; Seo YT; Jang YP; Kim GY
Environ Toxicol Pharmacol; 2013 Sep; 36(2):256-264. PubMed ID: 23686005
[TBL] [Abstract][Full Text] [Related]
9. Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
Park HJ; Lee SJ; Cho J; Gharbi A; Han HD; Kang TH; Kim Y; Lee Y; Park WS; Jung ID; Park YM
J Nat Prod; 2018 Jun; 81(6):1435-1443. PubMed ID: 29851490
[TBL] [Abstract][Full Text] [Related]
10. Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia.
Cruzat VF; Bittencourt A; Scomazzon SP; Leite JS; de Bittencourt PI; Tirapegui J
Nutrition; 2014 May; 30(5):602-11. PubMed ID: 24698353
[TBL] [Abstract][Full Text] [Related]
11. α-Lipoic acid attenuates LPS-induced cardiac dysfunction through a PI3K/Akt-dependent mechanism.
Jiang S; Zhu W; Li C; Zhang X; Lu T; Ding Z; Cao K; Liu L
Int Immunopharmacol; 2013 May; 16(1):100-7. PubMed ID: 23562296
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
Ding R; Han J; Zhao D; Hu Z; Ma X
Int Immunopharmacol; 2016 Nov; 40():125-130. PubMed ID: 27588912
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.
Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ
Shock; 1997 Nov; 8(5):349-56. PubMed ID: 9361345
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine Attenuates Cardiac Dysfunction in Endotoxemia and Sepsis by Promoting Neutrophil Migration.
Chen J; Wang B; Lai J; Braunstein Z; He M; Ruan G; Yin Z; Wang J; Cianflone K; Ning Q; Chen C; Wang DW
Front Immunol; 2018; 9():2015. PubMed ID: 30233596
[No Abstract] [Full Text] [Related]
16. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
17. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice.
Schabbauer G; Tencati M; Pedersen B; Pawlinski R; Mackman N
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1963-9. PubMed ID: 15319270
[TBL] [Abstract][Full Text] [Related]
18. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling.
Zhong W; Qian K; Xiong J; Ma K; Wang A; Zou Y
Biomed Pharmacother; 2016 Oct; 83():302-313. PubMed ID: 27393927
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.
Zhu Z; Aref AR; Cohoon TJ; Barbie TU; Imamura Y; Yang S; Moody SE; Shen RR; Schinzel AC; Thai TC; Reibel JB; Tamayo P; Godfrey JT; Qian ZR; Page AN; Maciag K; Chan EM; Silkworth W; Labowsky MT; Rozhansky L; Mesirov JP; Gillanders WE; Ogino S; Hacohen N; Gaudet S; Eck MJ; Engelman JA; Corcoran RB; Wong KK; Hahn WC; Barbie DA
Cancer Discov; 2014 Apr; 4(4):452-65. PubMed ID: 24444711
[TBL] [Abstract][Full Text] [Related]
20. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway.
Li ST; Dai Q; Zhang SX; Liu YJ; Yu QQ; Tan F; Lu SH; Wang Q; Chen JW; Huang HQ; Liu PQ; Li M
Acta Pharmacol Sin; 2018 Aug; 39(8):1294-1304. PubMed ID: 29323338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
